Anlv BiotechnologyTirzepatide
Ordered Tirzepatide from Anlv Biotechnology? Mail in a sample (US only) and let us test it for free.
Test my supplyAnlv Biotechnology's Tirzepatide signal is mixed: one 98.81% purity miss is followed by a clean pass streak. The later data support recovery, but a +29% fill result and thin batch IDs keep the evidence less clean than top profiles.
Corporate records are thinner than the sales trail: a Hebei entity lead, a WhatsApp-linked representative, and a managed Alibaba Cloud domain still do not resolve ownership. The report maps retained precursor-catalog exposure and co-hosted infrastructure.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Anlv Biotechnology rows.
Cancel anytime
About Anlv Biotechnology test results from Finnrick
Anlv Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 21 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Anlv Biotechnology peptides in this dataset are Cagrilintide (1 test), GHK-Cu (5 tests) and Retatrutide (1 test). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 21 recent tests.
Ordered Tirzepatide from Anlv Biotechnology? Mail in a sample (US only) and let us test it for free.
Test my supply